Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
An estimated 60% of all human genes undergo alternative splicing, a highly regulated process that produces splice variants with different functions. Such variants have been linked to a variety of cancers, and genetic diseases such as thalassemia and cystic fibrosis. This Perspective describes a prom...
Guardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2003
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171400/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12925686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19547 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|